Epitalon Peptide: A Complete Evidence-Based Guide

Epitalon peptide, also referred to as Epithalon, is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly, written in single-letter code as AEDG. It contains four amino acid residues: alanine, glutamic acid, aspartic acid, and glycine. The basic structure is a linear peptide with unmodified amino and carboxyl termini. [1]

Similarity of names can lead to confusing Epitalon with Epithalamin. The first name refers to a specific tetrapeptide, and the second to a complex peptide preparation historically associated with pineal extracts. These are not synonyms.

In this article, we discuss the chemical identity of AEDG, how to read the sequence, the types of structural differences, and the significance of analytical data. The description does not cover applications, dosage, or product comparisons.

Epitalon, Epithalon, and AEDG — how to understand the names?

Epitalon and Epithalon are alternative spellings used in literature for the tetrapeptide AEDG. The spelling Epithalone is also encountered. AEDG, on the other hand, is an abbreviation of the sequence, not another name for a multi-ingredient preparation.

Searching for publications under different name variants can help find related works. However, it does not exempt one from determining which material was actually used in each study.

Term	Meaning in this article
Epitalon	Name of the tetrapeptide AEDG
Epithalon	Alternative spelling of the name of this tetrapeptide
Epitalon	Additional name variant found in literature
AEDG	Single-letter sequence notation
Ala-Glu-Asp-Gly	Three-letter code of the same sequence
Epithalamin	Name of the complex peptide preparation, not the AEDG synonym

The name identifies the expected reference structure. This does not yet prove the identity of any sample so labeled.

Epitalon and Epithalamin — the most important distinction

The history of Epitalon is linked to research on Epithalamin, a preparation derived from pineal tissue. A 2025 historical review describes the development of synthetic AEDG based on the amino acid composition of this material. [2]

However, a defined tetrapeptide and a peptide extract are not the same chemical entity. An extract may contain multiple components, whereas the name of a single sequence indicates a specific molecular unit.

Therefore, the information coming from the paper on Epithalamin does not automatically become information about purified AEDG. One must first check the material description, its composition, and the scope of identification.

Historical connection also does not justify calling every modern sample of Epitalon a „pineal gland extract.” The synthetic production of the peptide and the isolation of biological material are distinct processes.

What does the term „synthetic tetrapeptide” mean?

„Synthetic” describes the method of obtaining a compound through chemical reactions. „Tetrapeptide” means a peptide containing four amino acid residues.

None of these terms constitutes an independent result of the analysis. The synthesis may be directed toward a specific structure, but its achievement must be confirmed. On the other hand, the number of four residues is not sufficient to distinguish all tetrapeptides.

Nor should a short sequence be equated with the simplicity of every chemical issue. Even a small peptide can exist as various isomers, derivatives, or material forms.

Amino acid sequence of Epitalon

The AEDG sequence is read from the amino end, N, to the carboxy end, C. Successive letters correspond to the residues shown in the table.

Position	Single-letter code	Three-letter code	Amino acid
1	A	Ala	Alanine
2	E	Glue	Glutamic acid
3	D	Asp	Aspartic acid
4	G	Gly	Glycine

In this notation, E stands for glutamic acid, and D for aspartic acid. They should not be confused with glutamine, denoted by Q, and asparagine, denoted by N. These are different amino acid residues. The rules for amino acid symbols are described by the IUPAC-IUB nomenclature. [3]

Order is part of a peptide's identity. AEDG is not just any list of four components.

Amino acid composition versus residue order

The amino acid composition indicates which residues are present and how many of each type there are. In AEDG, each of the four listed residues occurs once.

The sequence contains additional information: it establishes their order. A different arrangement of the same residues can yield a different peptide while maintaining the same elemental composition and mass.

Therefore, composition analysis does not replace complete sequence determination. The consistency of the amino acid list with expectations provides narrower information than confirming their order and linkage.

How does an amino acid residue differ from a free amino acid?

An amino acid residue is the part of an amino acid incorporated into the peptide structure. It is not an independent molecule floating next to the other components.

In the basic linear structure, four residues are linked by three peptide bonds. When calculating the formula of the product from the formulas of the four free amino acids, the formal subtraction of three water molecules is taken into account.

This is a structural balance, not a description of every possible synthesis method. Actual laboratory reactions may use protecting groups and activated derivatives, which the simplified balance does not show.

N- and C-termini and the notation H-Ala-Glu-Asp-Gly-OH

In the standard unmodified structure, the N-terminus is at the alanine residue, and the C-terminus is at the glycine residue. The notation H-Ala-Glu-Asp-Gly-OH emphasizes the absence of an additional covalent blockade at both ends.

This does not mean that the end groups maintain one unchanging protonation state under all conditions. Sequence notation and ionization description represent different features.

C-terminal amidation or N-terminal acetylation would constitute structural modifications. Such a derivative should not be treated as the same unmodified molecule just because the letter sequence AEDG is preserved.

Backbone bonds and side chains

In the basic structure of Epitalon, peptide bonds connect successive residues via groups attached to the α-amino acid backbone. Glu and Asp furthermore contain side-chain carboxyl groups.

The presence of an additional carboxyl group does not mean that it is the one forming a bond with the next residue. The point of connection must be read from the structure.

If the bond were routed through the side chain, the connectivity of the atoms would change. Such a variant would require a separate description, even if it contained the same types of amino acids.

In older representations discussed in the provided material, ambiguities regarding such connections occurred. In this article, the standard linear AEDG remains the point of reference; we do not treat a different drawing as a confirmed synonym for this structure.

Is Epitalon always a straight line in space?

„Linear describes how the residues are connected and the absence of a closed main chain ring. It does not imply a rigid, permanently straightened shape.

A peptide can adopt various conformations. They depend on intra-molecular interactions and its environment.

A drawing of an extended sequence, a computer model, and an experimentally determined structure are not the same kind of information. An illustrative graphic does not establish a single universal conformation for all conditions.

Stereochemistry of AEDG and the special role of glycine

In the standard description of Epitalon, alanine, glutamic acid, and aspartic acid have the L configuration. Glycine is achiral: there are two hydrogen atoms at its $\alpha$-carbon atom, which is why it is not assigned an L or D designation. [1,4]

Changing the configuration of one of the chiral residues leads to a different stereoisomer. It can have the same mass and empirical formula as the starting structure.

The letter D in the AEDG sequence should not be confused with the prefix D describing the configuration. In the sequence, D denotes an aspartic acid residue. Stereochemical information requires a different notation and appropriate context.

Chemical formula and molar mass

The empirical formula of unmodified Epitalon is C₁₄H₂₂N₄O₉. Its molar mass is approximately 390.35 g/mol. The PubChem record for this structure has the CID 219042. [1]

The formula can be verified by the balance of four free amino acids:

Balance sheet item	Pattern
Alanine	C₃H₇NO₂
Glutamic acid	C₅H₉NO₄
Aspartic acid	C₄H₇NO₄
Glycine	C₂H₅NO₂
Amount before formal water removal	C₁₄H₂₈N₄O₁₂
Subtraction of 3 H₂O for three peptide bonds	C₁₄H₂₂N₄O₉.

This balance does not confirm the order of the residues. Another sequence built from the same four amino acids can have an identical pattern.

Molar mass, monoisotopic mass and m/z

Molar mass expressed in g/mol and monoisotopic mass are not names of the same quantity. The former is sometimes calculated taking into account average atomic masses, while the latter refers to a specific set of isotopes.

A mass spectrometer records the mass-to-charge ratio of an ion, m/z. An ion can be formed by protonation, deprotonation, or adduct formation. Its signal should not be directly equated with the rounded molar mass of the neutral molecule.

Therefore, comparing documents requires checking what magnitude was given. An apparent difference in numbers does not necessarily mean a structural inconsistency, nor does a similar number constitute full proof of identity.

Ionization and the term „free base”

AEDG has an amino group and carboxyl groups, including the side groups of Glu and Asp. Their protonation depends on conditions, especially pH.

For this reason, generally referring to any form without a specified counterion as a „free base” is not very precise. It does not fully describe a peptide containing both acidic and basic groups simultaneously.

In the documentation, it is better to specify a particular chemical form or note that the unmodified peptide structure is being discussed. Without data, a specific salt, protonation state, or the composition of the entire material should not be added.

Counter-ion and peptide modification

A counterion and a covalently attached group to a peptide are different things. The presence of acetate as a component of the material is not the same as N-acetylation of the amino terminus.

N-acetylation changes the covalent structure of the molecule. The salt form, on the other hand, concerns the ionic composition and does not in itself imply a rearrangement of residues in the sequence.

Information	What does it describe?
AEDG	Order of residues
N-acetylated AEDG	Covalent N-terminal modification
Material containing acetate counterion	Ionic composition of the material
Hydration	Presence of water in a specific form of the material
Admixture of another peptide	Additional sample component

It is not possible to derive the entire material composition from the name Epitalon alone. The proportion of counterions and water may require separate determination.

Peptide mass and total sample mass

The total mass of the sample may include the peptide, water, counterions, and other components. It is not automatically equal to the mass of the AEDG itself.

Similarly, the result expressed for the dry material does not have to be directly comparable to the result for the as-received sample. The basis of calculation is part of the analytical information.

The distinction does not require discussing packaging or quantities to be used. It is a general principle of interpreting the chemical composition.

Synonym, analogue, fragment, and labeled peptide

A synonym is another name for the same chemical entity. An analog is a related structure, but does not have to be identical. A fragment covers only a part of the sequence.

The labeled peptide contains an additional tag, for example, a fluorescent group. Labeling can alter the mass, charge, and interactions of the molecule.

Therefore, the behavior of the labeled derivative should not be equated with that of the unmodified AEDG without additional evaluation. The observation of the label also requires determining whether it remains bound to the full peptide molecule.

Identity, purity, and content — three questions

Identity answers the question of what relationship has been identified. Purity refers to composition in terms of the adopted method. Content determines the amount of the substance being determined.

Question	Type of information
Does the detected component correspond to AEDG?	Identity
What other components were detected using the applied method?	Contaminant profile
What signal contribution was assigned to the main component?	Chromatographic purity according to a specific calculation
How many AEDGs are marked in the material?	Content

The result for one of these questions does not replace the answer to the others. The term „confirmed peptide” is insufficient if it is not known what was actually confirmed.

What does chromatography say?

Chromatography separates components based on their interaction with the separation system. Retention time and peak profile can support sample characterization.

However, the dominant peak alone does not determine the complete identity. Different components may co-elute, and not all of them are detected with the same sensitivity.

The percentage of peak area depends on the detector, conditions, and calculation method. It does not have to be equal to the mass percentage of AEDG in the entire material.

What do mass spectrometry and structural analysis contribute?

Mass spectrometry can provide information consistent with the expected ion mass and compound composition. Fragmentation analysis can support sequence determination.

This does not mean that every mass measurement will automatically distinguish all isomers or L and D configurations. The scope of identification depends on the data and the method used.

When ambiguity concerns atom connectivity or stereochemistry, suitably chosen additional methods may be needed, for example NMR spectroscopy or chiral analysis. There is no single number that replaces every type of characterization.

How to understand peptide stability?

Stability means maintaining specific characteristics under defined conditions and time. It should be indicated whether the structure, content, impurity profile, or physical properties were evaluated.

The result obtained for one matrix cannot be automatically assigned to another material. Also, the term „synthetic” or „short peptide” does not establish a shelf life.

This description does not provide instructions for dissolution or storage. It only explains why the stability claim requires conditions and data, rather than following from the name itself.

Why is a shared name in publications not enough?

Works may concern unmodified AEDG, a derivative, mixture, extract, or insufficiently characterized material. First, the subject of the study must be determined.

Next, it is necessary to distinguish the type of information: an analytical result, a computer model, a cell experiment, or a whole-organism observation. These are different levels of description, even if the authors use similar vocabulary.

A human cell line is not a clinical trial in participants. A docking model is not in itself experimental confirmation of binding. The result of an extract does not automatically determine the characteristics of a single tetrapeptide.

Frequently asked questions about Epitalon

What is Epitalon?

Epitalon is a tetrapeptide with the AEDG sequence. The basic description refers to a specific linear structure of four amino acid residues. The name does not automatically describe the composition of any given sample or all of its properties. When reading documentation, one must distinguish between the reference structure, the method of preparation, and the results of the analysis of the tested material.

Are Epitalon and Epithalon the same peptide?

In the literature, these names are used for the same tetrapeptide AEDG. The difference in spelling does not in itself imply a new sequence. However, additional terms regarding modification, labeling, or chemical form may provide important information. Therefore, in addition to the name, the full structural description should be checked.

Is Epithalamin a synonym for Epitalon?

No. Epithalamin is the name of a complex peptide preparation historically related to pineal extracts. Epitalon refers to a defined tetrapeptide. Their historical relationship does not remove the difference between a mixture and a single compound. Findings concerning one material should not be automatically attributed to the other.

What does AEDG mean?

AEDG represents successive residues of alanine, glutamic acid, aspartic acid, and glycine. It is a record of the sequence from the N-terminus to the C-terminus. The letters are not an arbitrary list of components. Changing their order changes the described structure, even if all four types of amino acids are still present in the same number.

Does the D in AEDG stand for configuration D?

No. In the single-letter sequence code, D stands for aspartic acid. The D stereochemical prefix has a different function and requires proper notation. Confusing these meanings can lead to an incorrect description of the structure. In the basic AEDG, the Asp residue has the L configuration.

Are all residues in Epitalon in the L-configuration?

Alanine, glutamic acid, and aspartic acid have the L configuration in their standard structure. Glycine is achiral, so neither the L nor D configuration is assigned to it. The phrase „four L-amino acids” would be imprecise in this case. Stereochemistry should be described taking into account the structure of each residue.

How many peptide bonds does the basic AEDG contain?

A linear tetrapeptide contains three bonds connecting four consecutive residues. This is information about the basic backbone. The number of bonds should not be equated with a full description of the structure, because the sequence, points of attachment, configuration, and end groups are also important. Four residues do not mean four connections in an open chain.

Does a linear peptide always have a straight shape?

No. Linearity refers to the connection of residues into an open chain. Conformation describes its spatial arrangement and can change. The drawing of a straight chain helps show the sequence, but it does not prove that the molecule maintains such a shape in solution or in any other situation.

Does the same mass mean the same sequence?

No. Rearranging the same residues can leave the pattern and mass unchanged. Stereochemical differences also do not necessarily change the mass. A matching mass signal supports identification, but its significance depends on the other data. It does not automatically replace the determination of sequence, configuration, or atom connectivity.

Do acetate and acetylation mean the same thing?

No. Acetate can act as a counterion or an additional component of the material. Acetylation means the covalent attachment of an acetyl group at a specific site. These are distinct chemical situations. In the description of AEDG, they must be separated, because only the second one directly modifies the peptide structure in the discussed sense.

Is labeled Epitalon identical to unlabeled?

The addition of a tag alters the structure of the analyzed molecule. It can also affect its behavior. Therefore, the results obtained for the labeled derivative require interpretation that takes this modification into account. The mere detection of the tag signal does not always determine whether the full, unmodified peptide or the material resulting from its conversion was observed.

Does high chromatographic purity define the entire sample?

A chromatographic result describes what was detected and calculated by a given method. It does not necessarily account for water, counterions, or components invisible to the detector used. Nor is it standalone confirmation of all structural details. Identity, impurity profile, and assay should be interpreted as distinct pieces of information.

Does the synthesis confirm the quality of the peptide?

Synthesis defines the method for obtaining a material targeted at a given structure. It is not the result of a quality test. Identity confirmation and component characterization require data specific to a particular sample. Nor does the name of the process determine stability or other characteristics, which must be evaluated separately under appropriate conditions.

Does the chemical description confirm the biological application?

The description of the structure answers the question about the composition of the compound. It does not independently establish its behavior in every model or outcome in humans. Sequence, mass, and analytical identity are the foundations of correct documentation, but they do not replace studies that answer other questions. The scope of the conclusion should remain consistent with the scope of the data.

Disclaimer

This article is for educational and scientific-informative purposes only and does not constitute medical advice, diagnosis, therapeutic guidelines, or a recommendation for the use of Epitalon. Epitalon/Epithalon (AEDG; Ala-Glu-Asp-Gly) remains an experimental peptide. The article is educational in nature and covers the nomenclature, history, and chemical characteristics of Epitalon. It does not constitute medical advice, a purchase recommendation, or instructions for the preparation, dosing, administration, or use of peptides. Confirmation of structure or purity is not proof of human safety or efficacy. The text does not evaluate the legal status of specific products.

References

[1] NCBI, PubChem. Epitalon, CID 219042. Epitalon structural record. The record was used to identify the reference structure; the formula balance presented in the text is a calculation based on the sequence composition.

[2] Araj, S. K., Brzezik, J., Mądra-Gackowska, K., & Szeleszczuk, Ł. (2025). Overview of Epitalon—Highly Bioactive Pineal Tetrapeptide with Promising Properties. International Journal of Molecular Sciences, 26(6), 2691. Review used for historical context and name differentiation. The bibliographic title was kept in the original; benefit claims were not transferred from it.

[3] IUPAC–IUB Joint Commission on Biochemical Nomenclature. Nomenclature and Symbolism for Amino Acids and Peptides. Names of amino acids and the basics of nomenclature.

[4] IUPAC–IUB Joint Commission on Biochemical Nomenclature. Nomenclature and Symbolism for Amino Acids and Peptides, sections 3AA-3 to 3AA-5. L/D configuration and achirality of glycine.